Clinical Trial Update: Pravastatin for Hyperlipidaemia in HIV. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating pravastatin for hyperlipidemia in HIV-infected individuals has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• HIV Infection
• Hyperlipidemia
• Lipodystrophy

Drugs mentioned

• Pravastatin (pravastatin)

Snippet

Sponsor: Kirby Institute | Conditions: HIV Infections, Lipid Metabolism | Phase 4 | Status: COMPLETED